Valeo Pharma Inc. is a specialty pharmaceutical company focused on acquiring, in-licensing and commercializing innovative pharmaceutical products with a primary focus on neurodegenerative diseases, women's health, Oncology and supportive care as well as hospital products. Valeo's shares trade on the CSE ("VPH")
Stock Exchange: CSE
Stock Ticker: VPH
16667, Hymus Boul.
Investor Relation contact
Senior Vice-President, and Chief Financial Officer